Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
11.08
-0.17 (-1.51%)
Apr 9, 2026, 3:04 PM CST
SHE:002728 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 126.15 | 457.41 | 647.25 | 739.66 | 372.47 |
Trading Asset Securities | 210 | - | - | - | - |
Cash & Short-Term Investments | 336.15 | 457.41 | 647.25 | 739.66 | 372.47 |
Cash Growth | -26.51% | -29.33% | -12.49% | 98.58% | -35.24% |
Accounts Receivable | 253.59 | 205.32 | 156 | 133.02 | 126.66 |
Other Receivables | 0.8 | 9.38 | 13.94 | 16.87 | 1.36 |
Receivables | 254.39 | 214.7 | 169.94 | 149.9 | 128.02 |
Inventory | 237.63 | 264.38 | 271.83 | 208.23 | 195.31 |
Prepaid Expenses | - | - | - | - | 0.69 |
Other Current Assets | 29.43 | 14.46 | 16.13 | 31.08 | 15.45 |
Total Current Assets | 857.6 | 950.95 | 1,105 | 1,129 | 711.95 |
Property, Plant & Equipment | 733.31 | 721.4 | 656.49 | 648.01 | 601.68 |
Long-Term Investments | 13.5 | 13.5 | 13.5 | 13.5 | - |
Goodwill | 517.6 | 517.6 | 529.23 | 542.4 | 542.4 |
Other Intangible Assets | 141.22 | 138.63 | 151.24 | 153.87 | 156.75 |
Long-Term Deferred Tax Assets | 28.43 | 21.85 | 18.4 | 18.81 | 17.18 |
Long-Term Deferred Charges | 7.29 | 17.41 | 13.45 | 11.48 | 15.6 |
Other Long-Term Assets | 12.47 | 19.54 | 25.18 | 28.67 | 20.65 |
Total Assets | 2,311 | 2,401 | 2,513 | 2,546 | 2,066 |
Accounts Payable | 68.63 | 44.83 | 83 | 76.29 | 52.35 |
Accrued Expenses | 40.62 | 19.37 | 32.5 | 30.42 | 20.09 |
Short-Term Debt | 263.54 | 516.09 | 306 | 633.68 | 377 |
Current Portion of Long-Term Debt | - | - | - | 213.5 | - |
Current Income Taxes Payable | 3.92 | 0.72 | 13.65 | 4.86 | 8.59 |
Current Unearned Revenue | 62.18 | 11.05 | 24.26 | 130.69 | 31.06 |
Other Current Liabilities | 15.45 | 3.96 | 6.36 | 19.81 | 7.25 |
Total Current Liabilities | 454.33 | 596.02 | 465.77 | 1,109 | 496.34 |
Long-Term Debt | - | - | - | - | 285.18 |
Long-Term Unearned Revenue | 17.27 | 20.57 | 20.77 | 18.51 | 11.72 |
Long-Term Deferred Tax Liabilities | 18.36 | 19.36 | 15.42 | 14.71 | 11.27 |
Total Liabilities | 489.96 | 635.94 | 501.95 | 1,142 | 804.51 |
Common Stock | 513.31 | 512.21 | 364.69 | 229.18 | 221.64 |
Additional Paid-In Capital | 849.97 | 844.13 | 982 | 575.92 | 460.91 |
Retained Earnings | 552.53 | 495.8 | 657.68 | 553.51 | 519.38 |
Treasury Stock | -101.19 | -93.86 | - | - | - |
Comprehensive Income & Other | 6.85 | 6.65 | 6.31 | 44.53 | 59.75 |
Shareholders' Equity | 1,821 | 1,765 | 2,011 | 1,403 | 1,262 |
Total Liabilities & Equity | 2,311 | 2,401 | 2,513 | 2,546 | 2,066 |
Total Debt | 263.54 | 516.09 | 306 | 847.18 | 662.18 |
Net Cash (Debt) | 72.61 | -58.68 | 341.25 | -107.52 | -289.71 |
Net Cash Per Share | 0.14 | -0.11 | 0.74 | -0.25 | -0.72 |
Filing Date Shares Outstanding | 499.58 | 500.58 | 510.56 | 449.27 | 434.42 |
Total Common Shares Outstanding | 499.58 | 499.49 | 510.56 | 449.19 | 434.42 |
Working Capital | 403.27 | 354.93 | 639.39 | 19.62 | 215.61 |
Book Value Per Share | 3.65 | 3.53 | 3.94 | 3.12 | 2.90 |
Tangible Book Value | 1,163 | 1,109 | 1,330 | 706.87 | 562.55 |
Tangible Book Value Per Share | 2.33 | 2.22 | 2.61 | 1.57 | 1.29 |
Buildings | 608.2 | 527.78 | 542.22 | 412.29 | 419.33 |
Machinery | 439.2 | 418.7 | 329.97 | 259.01 | 254.01 |
Construction In Progress | 118.38 | 157.88 | 131.95 | 280.88 | 198.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.